SP-MHCI-0364-3

Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

US$507.00

In stock

Description

About Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

The Human Cytomegalovirus (HCMV) (strain AD169) Immediate early protein IE1 Peptide (IEDB: 13133) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Immediate early protein Peptide, H-ELKRKMIYM-OH (Uniprot: Genbank: AKI20200.1 aa: 199-207) from JPT is produced under strict quality control and quality management.

Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM - Specifications

  • Peptide sequence: H-ELKRKMIYM-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Herpes
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

References:
Read References with JPT’s Antigen Peptides
Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM has been described in:
Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection., J Immunol, 2004 (PMID: 15585874)
Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response., J Virol, 2000 (PMID: 10756006)
Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes., J Clin Invest, 2018 (PMID: 29851415)

Documentation

Documentation for Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

Properties

Properties of Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Herpes
Layout: Freeze-dried in glass vial
Organism: Human Cytomegalovirus (HCMV)
Protein Name: Immediate early protein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

Information Values
Sequence: H-ELKRKMIYM-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote